BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

755 related articles for article (PubMed ID: 29369216)

  • 1. Helicobacter pylori eradication may influence timing of endoscopic surveillance for gastric cancer in patients with gastric precancerous lesions: A retrospective study.
    Dore MP; Cipolli A; Ruggiu MW; Manca A; Bassotti G; Pes GM
    Medicine (Baltimore); 2018 Jan; 97(4):e9734. PubMed ID: 29369216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori infection, glandular atrophy and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer and early gastric cancer.
    Zhang C; Yamada N; Wu YL; Wen M; Matsuhisa T; Matsukura N
    World J Gastroenterol; 2005 Feb; 11(6):791-6. PubMed ID: 15682469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precancerous conditions after H. pylori eradication: a randomized double blind study in first degree relatives of gastric cancer patients.
    Massarrat S; Haj-Sheykholeslami A; Mohamadkhani A; Zendehdel N; Rakhshani N; Stolte M; Mirzaei M; Saliminejhad M; Saeidi S; Shahidi M
    Arch Iran Med; 2012 Nov; 15(11):664-9. PubMed ID: 23102241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.
    Leung WK; Lin SR; Ching JY; To KF; Ng EK; Chan FK; Lau JY; Sung JJ
    Gut; 2004 Sep; 53(9):1244-9. PubMed ID: 15306578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions.
    Piazuelo MB; Bravo LE; Mera RM; Camargo MC; Bravo JC; Delgado AG; Washington MK; Rosero A; Garcia LS; Realpe JL; Cifuentes SP; Morgan DR; Peek RM; Correa P; Wilson KT
    Gastroenterology; 2021 Mar; 160(4):1106-1117.e3. PubMed ID: 33220252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori infection and precancerous lesions of the stomach.
    Haziri A; Juniku-Shkololli A; Gashi Z; Berisha D; Haziri A
    Med Arh; 2010; 64(4):248-9. PubMed ID: 21246927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of
    Mera RM; Bravo LE; Camargo MC; Bravo JC; Delgado AG; Romero-Gallo J; Yepez MC; Realpe JL; Schneider BG; Morgan DR; Peek RM; Correa P; Wilson KT; Piazuelo MB
    Gut; 2018 Jul; 67(7):1239-1246. PubMed ID: 28647684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.
    Liu KS; Wong IO; Leung WK
    World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development.
    Watari J; Chen N; Amenta PS; Fukui H; Oshima T; Tomita T; Miwa H; Lim KJ; Das KM
    World J Gastroenterol; 2014 May; 20(18):5461-73. PubMed ID: 24833876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
    Wong BC; Lam SK; Wong WM; Chen JS; Zheng TT; Feng RE; Lai KC; Hu WH; Yuen ST; Leung SY; Fong DY; Ho J; Ching CK; Chen JS;
    JAMA; 2004 Jan; 291(2):187-94. PubMed ID: 14722144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence of Helicobacter pylori infection and gastric cancer precursor lesions in patients with dyspepsia].
    Muller LB; Fagundes RB; Moraes CC; Rampazzo A
    Arq Gastroenterol; 2007; 44(2):93-8. PubMed ID: 17962851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Effects of
    Han SJ; Kim SG; Lim JH; Choi JM; Oh S; Park JY; Kim J; Kim JS; Jung HC
    Gut Liver; 2018 Mar; 12(2):133-141. PubMed ID: 29069890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication - a prospective study for up to 10 years.
    Hwang YJ; Kim N; Lee HS; Lee JB; Choi YJ; Yoon H; Shin CM; Park YS; Lee DH
    Aliment Pharmacol Ther; 2018 Feb; 47(3):380-390. PubMed ID: 29193217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.
    You WC; Brown LM; Zhang L; Li JY; Jin ML; Chang YS; Ma JL; Pan KF; Liu WD; Hu Y; Crystal-Mansour S; Pee D; Blot WJ; Fraumeni JF; Xu GW; Gail MH
    J Natl Cancer Inst; 2006 Jul; 98(14):974-83. PubMed ID: 16849680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia.
    Liu D; He Q; Liu C
    J Gastroenterol Hepatol; 2010 Apr; 25(4):795-9. PubMed ID: 20492336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori eradication and antral intestinal metaplasia--two years follow-up study.
    Ciok J; Dzieniszewski J; Lucer C
    J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():115-22. PubMed ID: 9440062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric precancerous lesions are associated with gene variants in Helicobacter pylori-susceptible ethnic Malays.
    Maran S; Lee YY; Xu S; Rajab NS; Hasan N; Syed Abdul Aziz SH; Majid NA; Zilfalil BA
    World J Gastroenterol; 2013 Jun; 19(23):3615-22. PubMed ID: 23801863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Gastritis and Gastric Cancer Risk in the Chilean Population Using the OLGA System.
    Bellolio E; Riquelme I; Riffo-Campos AL; Rueda C; Ferreccio C; Villaseca M; Brebi P; Muñoz S; Araya JC
    Pathol Oncol Res; 2019 Jul; 25(3):1135-1142. PubMed ID: 30467699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis.
    Ito M; Haruma K; Kamada T; Mihara M; Kim S; Kitadai Y; Sumii M; Tanaka S; Yoshihara M; Chayama K
    Aliment Pharmacol Ther; 2002 Aug; 16(8):1449-56. PubMed ID: 12182744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial).
    Aumpan N; Vilaichone RK; Pornthisarn B; Chonprasertsuk S; Siramolpiwat S; Bhanthumkomol P; Nunanan P; Issariyakulkarn N; Ratana-Amornpin S; Miftahussurur M; Mahachai V; Yamaoka Y
    PLoS One; 2021; 16(8):e0255601. PubMed ID: 34379655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.